Efficacy of gonadotropin-releasing hormone agonist addition for luteal phase support in women with repeated implantation failure undergoing intracytoplasmic sperm injection cycles - intracytoplasmic sperm injection cycles .Gonadotropin releasing hormone.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 14 Sep 2016
At a glance
- Drugs Triptorelin (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- 20 Jan 2014 According to the Iranian Registry of Clinical Trials, Planned End Date changed from 22 Dec 2012 to 22 Dec 2013.
- 20 Jan 2014 According to the Iranian Registry of Clinical Trials, Status changed from recruiting to active, no longer recruiting.
- 15 May 2013 New trial record